A Pain Rx That Resists Abuse
The US Food and Drug Administration (FDA) has approved a new opioid with abuse-deterrent properties.
Nuplazid Gets FDA Go-Ahead
The US Food and Drug Administration (FDA) has approved Nuplazid (pimavanserin) tablets to treat hallucinations and delusions in patients with Parkinson's disease.
Top 10 Items For Your Medicine Cabinet
What’s in your medicine cabinet? Did your items make our top 10 list?
Seizure Rx May Cut Dosing in Half
Who wants to take medication twice a day when you can take it once a day?
Antipsychotics for Parkinson's: The Problem
Physicians commonly prescribe antipsychotic drugs to treat psychosis associated with Parkinson's. However, a new study published in JAMA Neurology suggests that these drugs may be causing additional harm.
Stay Active to Stay Sharp
Need another reason to exercise? Reducing your risk of Alzheimer's may be as simple as working in the garden or taking a walk each day.
The Link Between Gum Health and Cognition
In a new study, gum disease was linked to faster cognitive decline in patients with Alzheimer's disease.
Headache and IBS: A Potential Link
A relationship between headaches and irritable bowel syndrome (IBS)? Surprisingly, there may be one.
Got Chronic Neck Pain? Stop Smoking Now!
It’s a well-known fact — cigarettes are bad for your health. Just how far the negative health effects of cigarettes reach, however, may come as a surprise to many.
New Epilepsy Rx Gets FDA Nod
The U.S. Food and Drug Administration yesterday approved Briviact (brivaracetam) as an add-on treatment to other medications to treat partial onset seizures in patients age 16 years and older with epilepsy.